Hideto Kawaratani

Sodium glucose cotransporter 2 inhibitor canagliflozin attenuates liver cancer cell growth and angiogenic activity by inhibiting glucose uptake

Kosuke Kaji, Norihisa Nishimura, Kenichiro Seki et al. · International Journal of Cancer · 2017 · 247 citations

Medicine, Oncology, Pharmacology +16

Gut Dysbiosis Associated With Hepatitis C Virus Infection

Takako Inoue, Jiro Nakayama, Kei Moriya et al. · Clinical Infectious Diseases · 2018 · 186 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats

Kosuke Kaji, Hitoshi Yoshiji, Yasuhide Ikenaka et al. · Journal of Gastroenterology · 2013 · 130 citations

Medicine, Molecular Biology, Pharmacology +16

Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity

Kosuke Kaji, Hiroaki Takaya, Soichiro Saikawa et al. · World Journal of Gastroenterology · 2017 · 102 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma

Hitoshi Yoshiji, Ryuichi Noguchi, Masahisa Toyohara et al. · Journal of Hepatology · 2009 · 89 citations

Medicine, Oncology, Pharmacology +12